Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Tesamorelin Effects on Liver Fat and Histology in HIV: A Collaborative UO1 Grant

Trial Profile

Tesamorelin Effects on Liver Fat and Histology in HIV: A Collaborative UO1 Grant

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 27 Nov 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Tesamorelin (Primary)
  • Indications Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Nov 2019 According to an Theratechnologies media release, the company announced that Philippe Dubuc, the company's CFO will attend the Piper Jaffray 31st Annual Healthcare and will hold several meetings with representatives from various investment firms to discuss the latest developments announced by the company including the publication of clinical trial results in the Lancet HIV.
    • 14 Oct 2019 Results presented in a Theratechnologies media release.
    • 11 Oct 2019 Results presened in a Theratechnologies Media Release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top